Waganesh Zeleke is associate professor of mental health counseling at Duquesne University in Pittsburgh, Pennsylvania. She is a licensed clinical professional counselor and a nationally certified counselor. She serves as an associate editor for Frontiers in Education: Special Educational Needs and as guest editor for different journals. Zeleke published more than 35 scholastic articles in peer-reviewed journals on various topics, including autism in Africa, mental health disparity, child and family relationships, international adoption, trauma and immigrant health.
Waganesh Zeleke
Associate professor
Duquesne University
From this contributor
Remembering Zemi Yenus: An ambassador for autism in Africa
Zemi Yenus was the mother of a child with autism, founder of Ethiopia’s first school for autistic children and a tireless advocate for autism awareness and research in Africa.
Remembering Zemi Yenus: An ambassador for autism in Africa
By
Rosa Hoekstra, Andy Shih, Bethlehem Tekola, Waganesh Zeleke
15 June 2021 | 13 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read